Literature DB >> 25142489

Mechanisms of exertional dyspnoea in pulmonary veno-occlusive disease with EIF2AK4 mutations.

Pierantonio Laveneziana1, David Montani2, Peter Dorfmüller3, Barbara Girerd4, Olivier Sitbon4, Xavier Jaïs4, Laurent Savale4, Mélanie Eyries5, Florent Soubrier5, Thomas Similowski6, Gérald Simonneau4, Marc Humbert4, Gilles Garcia7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25142489     DOI： 10.1183/09031936.00088914

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  5 in total

1.  Effects of non-fatiguing respiratory muscle loading induced by expiratory flow limitation during strenuous incremental cycle exercise on metabolic stress and circulating natural killer cells.

Authors:  Camille Rolland-Debord; Capucine Morelot-Panzini; Thomas Similowski; Roberto Duranti; Pierantonio Laveneziana
Journal:  Pflugers Arch       Date:  2017-09-26       Impact factor: 3.657

2.  Mutation in BMPR2 Promoter: A 'Second Hit' for Manifestation of Pulmonary Arterial Hypertension?

Authors:  Rebecca Rodríguez Viales; Christina A Eichstaedt; Nicola Ehlken; Christine Fischer; Mona Lichtblau; Ekkehard Grünig; Katrin Hinderhofer
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

Review 3.  Measurement and Interpretation of Exercise Ventilatory Efficiency.

Authors:  Devin B Phillips; Sophie É Collins; Michael K Stickland
Journal:  Front Physiol       Date:  2020-06-25       Impact factor: 4.566

Review 4.  Pulmonary capillary hemangiomatosis: a focus on the EIF2AK4 mutation in onset and pathogenesis.

Authors:  Lijiang Ma; Ruijun Bao
Journal:  Appl Clin Genet       Date:  2015-08-07

5.  A simple method to assess in vivo proliferation in lung vasculature with EdU: the case of MMC-induced PVOD in rat.

Authors:  Antigny Fabrice; Ranchoux Benoît; Nadeau Valérie; Edmund Lau; Bonnet Sébastien; Perros Frédéric
Journal:  Anal Cell Pathol (Amst)       Date:  2015-08-09       Impact factor: 2.916
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.